-
581
Editorial: Immunology of food-borne parasites: recent progress and future advances
Published 2025-01-01Get full text
Article -
582
-
583
Advances in neuromodulation for treatment of prolonged disorders of consciousness
Published 2025-01-01Get full text
Article -
584
Modifiable factors for irritable bowel syndrome: evidence from Mendelian randomisation approach
Published 2025-01-01Get full text
Article -
585
Exome-wide genetic risk score (ExGRS) to predict high myopia across multi-ancestry populations
Published 2024-12-01Get full text
Article -
586
-
587
Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study
Published 2025-01-01“…Guanglu Jiang,1,* Rongmei Liu,2,* Yi Xue,1 Qiping Ge,2 Lihui Nie,2 Zizheng Lv,2 Zhongshun Kong,2 Jin Shi,2 Hongmei Chen,2 Hua Li,2 Xiaoguang Wu,2 Li Xie,2 Yanhua Song,2 Hairong Huang,1 Mengqiu Gao2 1National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Mengqiu Gao; Hairong Huang, Email gaomqwdm@aliyun.com; huanghairong@tb123.orgBackground: Contezolid (CZD) is an analog of Linezolid (LZD) that has demonstrated potent in vitro and in vivo activity against tuberculosis (TB) while presenting a safer side-effect profile. …”
Get full text
Article -
588
-
589
-
590
-
591
-
592
-
593
-
594
-
595
The Modulation of Laser Refractive Surgery on Sensory Eye Dominance of Anisometropia
Published 2020-01-01Get full text
Article -
596
-
597
-
598
Analysis of the correlation between the dose exposure intensity and apatinib in advanced gastric cancer: a retrospective cohort study
Published 2025-02-01“…This study amid to evaluate the correlation between dose exposure intensity and efficacy and safety of apatinib in the treatment of advanced gastric cancer.MethodsWe conducted an observational, retrospective cohort study of patients with advanced gastric cancer who received apatinib targeted therapy in Beijing Friendship Hospital affiliated to Capital Medical University between June 1, 2018, and June 30, 2021. …”
Get full text
Article -
599
Low-Dose Taxol Promotes Neuronal Axons Extension and Functional Recovery after Spinal Cord Injury
Published 2023-01-01Get full text
Article -
600